Fantao Meng
Directeur Technique/Scientifique/R&D chez Hemoglobin Oxygen Therapeutics LLC
Postes actifs de Fantao Meng
Sociétés | Poste | Début | Fin |
---|---|---|---|
Hemoglobin Oxygen Therapeutics LLC
Hemoglobin Oxygen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Hemoglobin Oxygen Therapeutics LLC operates as a biotechnology company. It is focused on the development, manufacture and commercialization of a proprietary technology platform for oxygen-carrying solutions that address critical unmet medical needs in both human and veterinary medicine. The firm’s products include Hemopure and Oxyglobin. The company was founded by Zafiris G. Zafirelis and Igor Serov on February 18, 2014 and is headquartered in Souderton, PA. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Fantao Meng
Formation de Fantao Meng
Chinese Academy of Sciences | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 2 |
Chine | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Hemoglobin Oxygen Therapeutics LLC
Hemoglobin Oxygen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Hemoglobin Oxygen Therapeutics LLC operates as a biotechnology company. It is focused on the development, manufacture and commercialization of a proprietary technology platform for oxygen-carrying solutions that address critical unmet medical needs in both human and veterinary medicine. The firm’s products include Hemopure and Oxyglobin. The company was founded by Zafiris G. Zafirelis and Igor Serov on February 18, 2014 and is headquartered in Souderton, PA. | Health Technology |
- Bourse
- Insiders
- Fantao Meng
- Expérience